ACASTI PHARMA INC's ticker is ACST and the CUSIP is 00430K402. A total of 7 filers reported holding ACASTI PHARMA INC in Q3 2018. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2018 | $527,000 | – | 684,600 | – | 0.31% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Perceptive Advisors | 236,559 | $414,000 | 0.03% |
| INTACT INVESTMENT MANAGEMENT INC. | 89,490 | $206,000 | 0.01% |
| Virtu KCG Holdings LLC | 29,187 | $52,000 | 0.00% |
| TORONTO DOMINION BANK | 25 | $0 | 0.00% |
| BANK OF MONTREAL /CAN/ | 177,389 | $317,000 | 0.00% |
| Tower Research Capital LLC (TRC) | 600 | $1,000 | 0.00% |
| Renaissance Technologies | 35,400 | $63,000 | 0.00% |
| ROYAL BANK OF CANADA | 75 | $0 | 0.00% |
| UBS Group AG | 1,061 | $2,000 | 0.00% |